New Energy World Network: Connecting Investors, Innovators & Deal-Makers worldwide

Essential industry insights

cleantech --- renewables --- sustainability

Advanced
Search

Glycos Biotechnologies closes Series A funding on $5m

17 Apr 2009

Houston-based biotechnology company Glycos Biotechnologies has closed a Series A funding round on $5m. The round was led by venture capital firms Draper Fisher Jurvetson and DFJ Mercury.

 

Sorry, to read the full story you must be a Premium Subscriber

Legals & Terms of UsePrivacy Policy

NewNet is a trading name of New Energy World Network Ltd, registered in England (No. 06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © New Energy World Network (NewNet) 2008-2012